The FDA has granted breakthrough therapy designation to Hemab [...]

A single photobiomodulation session reduced bacterial load in acute burn [...]

Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

As Rare Disease Day 2026 shines a spotlight on patients [...]

ViiV Healthcare, the global specialist HIV company majority owned by [...]

Young adults in wealthy countries are four times more likely [...]

A new study confirms that Theranica’s Nerivio REN wearable for [...]

SolasCure has reported positive phase 2 data for Aurase Wound [...]

AC Immune has initiated a Phase 1 trial of its [...]

Fennec Pharmaceuticals has presented real world data supporting the integration [...]